| 1984 |
Joined Sankyo Co., Ltd.
|
| 2000 |
Vice President, Operation Planning and Management, Sankyo Pharma Development, Sankyo Pharma Inc. |
| 2003 |
Vice President, Operation Planning and Management, Sankyo Pharma Development, Sankyo Pharma Inc. |
| |
Board Member and Corporate Coordination, Luitpold Pharmaceuticals, Inc. (Present: American Regent, Inc.) |
| 2006 |
Senior Vice President, Corporate Coordination, Daiichi Sankyo Pharma Development, Daiichi Sankyo, Inc. |
|
Board Member and Corporate Coordination, Luitpold Pharmaceuticals, Inc. |
| 2013 |
Head, Corporate Services, Member of Executive Committee, Ranbaxy Laboratories Limited (a company of Daiichi Sankyo Group at that time) |
| 2015 |
Vice President, Business Planning, ASCA Company, Daiichi Sankyo Co., Ltd. |
| 2017 |
Corporate Officer, President, ASCA Company |
| 2018 |
Corporate Officer, Vice President of Corporate Communications Department, Corporate Planning & Management Division
|
| 2019 |
Corporate Officer of the Company, Head of US Corporate Division, Daiichi Sankyo, Inc. |
| 2023 |
Executive Corporate Officer, Head of Global Corporate Planning & Management, CFO of the Company
|
| 2024 |
Executive Corporate Officer, Head of Global Corporate Planning & Management, CFO of the Company, Dean of DS Academy (to present) |